These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid. Clayton PT; Mills KA; Johnson AW; Barabino A; Marazzi MG Gut; 1996 Apr; 38(4):623-8. PubMed ID: 8707100 [TBL] [Abstract][Full Text] [Related]
4. Bile acids and bile alcohols in a child with hepatic 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency: effects of chenodeoxycholic acid treatment. Ichimiya H; Egestad B; Nazer H; Baginski ES; Clayton PT; Sjövall J J Lipid Res; 1991 May; 32(5):829-41. PubMed ID: 2072042 [TBL] [Abstract][Full Text] [Related]
5. Abnormal bile acid metabolism and neonatal hemochromatosis: a subset with poor prognosis. Siafakas CG; Jonas MM; Perez-Atayde AR J Pediatr Gastroenterol Nutr; 1997 Sep; 25(3):321-6. PubMed ID: 9285385 [TBL] [Abstract][Full Text] [Related]
6. Resolution of liver biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism (delta 4-3-oxosteroid 5 beta-reductase deficiency). Daugherty CC; Setchell KD; Heubi JE; Balistreri WF Hepatology; 1993 Nov; 18(5):1096-101. PubMed ID: 8225213 [TBL] [Abstract][Full Text] [Related]
8. Lack of 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase/isomerase in fibroblasts from a child with urinary excretion of 3 beta-hydroxy-delta 5-bile acids. A new inborn error of metabolism. Buchmann MS; Kvittingen EA; Nazer H; Gunasekaran T; Clayton PT; Sjövall J; Björkhem I J Clin Invest; 1990 Dec; 86(6):2034-7. PubMed ID: 1979336 [TBL] [Abstract][Full Text] [Related]
9. Familial giant cell hepatitis with low bile acid concentrations and increased urinary excretion of specific bile alcohols: a new inborn error of bile acid synthesis? Clayton PT; Casteels M; Mieli-Vergani G; Lawson AM Pediatr Res; 1995 Apr; 37(4 Pt 1):424-31. PubMed ID: 7596681 [TBL] [Abstract][Full Text] [Related]
10. Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-Delta 5-C27-steroid dehydrogenase deficiency. Subramaniam P; Clayton PT; Portmann BC; Mieli-Vergani G; Hadzić N J Pediatr Gastroenterol Nutr; 2010 Jan; 50(1):61-6. PubMed ID: 19915491 [TBL] [Abstract][Full Text] [Related]
11. Tyrosinemia type I-like disease: a possible manifestation of 3-oxo-delta 4-steroid 5 beta-reductase deficiency. Kimura A; Endo F; Kagimoto S; Inoue T; Suzuki M; Kurosawa T; Tohma M; Fujisawa T; Kato H Acta Paediatr Jpn; 1998 Jun; 40(3):211-7. PubMed ID: 9695292 [TBL] [Abstract][Full Text] [Related]
12. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. Setchell KD; Schwarz M; O'Connell NC; Lund EG; Davis DL; Lathe R; Thompson HR; Weslie Tyson R; Sokol RJ; Russell DW J Clin Invest; 1998 Nov; 102(9):1690-703. PubMed ID: 9802883 [TBL] [Abstract][Full Text] [Related]
13. Detection of Δ4-3-oxo-steroid 5β-reductase deficiency by LC-ESI-MS/MS measurement of urinary bile acids. Muto A; Takei H; Unno A; Murai T; Kurosawa T; Ogawa S; Iida T; Ikegawa S; Mori J; Ohtake A; Hoshina T; Mizuochi T; Kimura A; Hofmann AF; Hagey LR; Nittono H J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 900():24-31. PubMed ID: 22695323 [TBL] [Abstract][Full Text] [Related]
14. Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy. Gonzales E; Gerhardt MF; Fabre M; Setchell KD; Davit-Spraul A; Vincent I; Heubi JE; Bernard O; Jacquemin E Gastroenterology; 2009 Oct; 137(4):1310-1320.e1-3. PubMed ID: 19622360 [TBL] [Abstract][Full Text] [Related]
15. [Clinical features of a Chinese infant with inborn error of bile acid metabolism-3β-hydroxy-Δ(5)-C27-steroid dehydrogenase deficiency and review of the literature]. Yang TJ; Xie XB; Yao WL; Wang HJ; Yu H; Wang XH Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):625-9. PubMed ID: 24225297 [TBL] [Abstract][Full Text] [Related]
16. Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. Lemonde HA; Custard EJ; Bouquet J; Duran M; Overmars H; Scambler PJ; Clayton PT Gut; 2003 Oct; 52(10):1494-9. PubMed ID: 12970144 [TBL] [Abstract][Full Text] [Related]
17. Tandem mass spectrometric determination of atypical 3β-hydroxy-Δ5-bile acids in patients with 3β-hydroxy-Δ5-C27-steroid oxidoreductase deficiency: application to diagnosis and monitoring of bile acid therapeutic response. Zhang W; Jha P; Wolfe B; Gioiello A; Pellicciari R; Wang J; Heubi J; Setchell KD Clin Chem; 2015 Jul; 61(7):955-63. PubMed ID: 25931455 [TBL] [Abstract][Full Text] [Related]
18. Molecular genetic and bile acid profiles in two Japanese patients with 3beta-hydroxy-DELTA5-C27-steroid dehydrogenase/isomerase deficiency. Mizuochi T; Kimura A; Ueki I; Takahashi T; Hashimoto T; Takao A; Seki Y; Takei H; Nittono H; Kurosawa T; Matsuishi T Pediatr Res; 2010 Sep; 68(3):258-63. PubMed ID: 20531254 [TBL] [Abstract][Full Text] [Related]
19. Differential interaction of bile acids from patients with inborn errors of bile acid synthesis with hepatocellular bile acid transporters. Stieger B; Zhang J; O'Neill B; Sjövall J; Meier PJ Eur J Biochem; 1997 Feb; 244(1):39-44. PubMed ID: 9063443 [TBL] [Abstract][Full Text] [Related]
20. Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid. Axelson M; Ellis E; Mörk B; Garmark K; Abrahamsson A; Björkhem I; Ericzon BG; Einarsson C Hepatology; 2000 Jun; 31(6):1305-12. PubMed ID: 10827156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]